Literature DB >> 20450247

Indirect maternal mortality increases in the Netherlands.

Joke M Schutte1, Layla de Jonge, Nico W E Schuitemaker, Job G Santema, Eric A P Steegers, Jos van Roosmalen.   

Abstract

OBJECTIVE: To assess causes, trends, and substandard care in indirect maternal mortality in the Netherlands.
DESIGN: Confidential enquiry into causes of maternal death.
SETTING: Nationwide in the Netherlands. POPULATION: A total of 2,557,208 live births.
METHODS: Data analysis of indirect maternal deaths in the period 1993-2005. MAIN OUTCOME MEASURES: Indirect maternal mortality.
RESULTS: Of the study subjects, 97 were classified as indirect deaths, representing a maternal mortality ratio of 3.3/100,000 live births, a significant increase compared to the preceding enquiry in the period 1983-1992 (MMR 2.4, OR 1.5, 95%CI 1.0-2.1). The percentage of cases not directly reported to the Maternal Mortality Committee decreased from 15 to 5%. Cardiovascular disorders were the leading cause of indirect maternal mortality, followed by cerebrovascular disorders. Vascular dissection (n = 19) was the most frequent specified cause of death. Risk factors were advanced maternal age, non-indigenous origin (Surinam and Dutch Antilles), and medical health risks before pregnancy. Substandard care was present in 35%, mainly being misjudgment of the severity of the condition and delay in initiating therapy.
CONCLUSION: The rise of mortality due to indirect causes is considered a reflection of the change in risk profile of women of childbearing age and the result of demographic alterations concerning ethnicity and maternal age. The identification of high risk groups, preferably by programs of preconception care, should lead to improved care for these women, with a multidisciplinary approach when needed.

Entities:  

Mesh:

Year:  2010        PMID: 20450247     DOI: 10.3109/00016341003657876

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  9 in total

Review 1.  Use of medication for cardiovascular disease during pregnancy.

Authors:  Petronella G Pieper
Journal:  Nat Rev Cardiol       Date:  2015-12       Impact factor: 32.419

Review 2.  Incidence of myocardial infarction in pregnancy: a systematic review and meta-analysis of population-based studies.

Authors:  Paul Gibson; Mariam Narous; Tabassum Firoz; Doris Chou; Maria Barreix; Lale Say; Matthew James
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2017-07-01

3.  Pregnancy associated death in record linkage studies relative to delivery, termination of pregnancy, and natural losses: A systematic review with a narrative synthesis and meta-analysis.

Authors:  David C Reardon; John M Thorp
Journal:  SAGE Open Med       Date:  2017-11-13

4.  Maternal mortality due to cardiovascular disease in the Netherlands: a 21-year experience.

Authors:  H Lameijer; J M Schutte; N W E Schuitemaker; J J M van Roosmalen; P G Pieper
Journal:  Neth Heart J       Date:  2020-01       Impact factor: 2.380

Review 5.  Maternal death analysis based on data from the nationwide registration system in Japan (2010-2018).

Authors:  Tomoko Wakasa; Hatsue Ishibashi-Ueda; Makoto Takeuchi
Journal:  Pathol Int       Date:  2021-02-09       Impact factor: 2.534

6.  Maternal mortality in Sweden 1988-2007: more deaths than officially reported.

Authors:  Annika Esscher; Ulf Högberg; Bengt Haglund; Birgitta Essën
Journal:  Acta Obstet Gynecol Scand       Date:  2012-12-04       Impact factor: 3.636

Review 7.  Obstetric Anesthesia and Heart Disease: Practical Clinical Considerations.

Authors:  Marie-Louise Meng; Katherine W Arendt
Journal:  Anesthesiology       Date:  2021-07-01       Impact factor: 8.986

8.  Ischaemic heart disease during pregnancy or post-partum: systematic review and case series.

Authors:  H Lameijer; M A M Kampman; M A Oudijk; P G Pieper
Journal:  Neth Heart J       Date:  2015-05       Impact factor: 2.380

9.  Reclassifying causes of obstetric death in Mexico: a repeated cross-sectional study.

Authors:  Margaret C Hogan; Biani Saavedra-Avendano; Blair G Darney; Luis M Torres-Palacios; Ana L Rhenals-Osorio; Bertha L Vázquez Sierra; Patricia N Soliz-Sánchez; Emmanuela Gakidou; Rafael Lozano
Journal:  Bull World Health Organ       Date:  2016-05-02       Impact factor: 9.408

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.